Related Experiment Video
Updated: Aug 7, 2026

Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats
Published on: April 7, 2023
Management of bone loss induced by aromatase inhibitors
1Department of Surgery-Medical, University of Vienna, Austrian Breast and Colorectal Cancer Study Group, Vienna, Austria. michael.gnant@meduniwien.ac.at
Abstract:
Aromatase inhibitors are quickly becoming standard adjuvant endocrine therapy for hormone-receptor positive breast cancer, either upfront or in sequence after tamoxifen. As other means of estrogen-depleting therapy, decreasing bone mineral density is the major side effect of this treatment. As increase in fracture incidence have already been reported in most major trials of aromatase inhibitors. Bisphosphonates are used to treat this cancer-treatment induced bone loss, the available data is reviewed here.
Related Concept Videos
Bone Remodeling
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Osteoclasts in Bone Remodeling
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Aortic Regurgitation III: Medical Management
Menopause